Shaking my head after reading this but happy also to be
Shaking my head after reading this but happy also to be invested in Dalton and his mission to help fix it!
$UNVC/MERCK/MARIMED/AGRIMED/SATIVEO/TELEDOC/AETNA/HCI TO $5.00PLUS
https://www.google.com/amp/s/www.bostonherald...tions/amp/
Ex-pharma CEO pleads guilty to kickbacks to doctors for opioid prescriptionsJonathan Ng and Sean Philip Cotter
PUBLISHED: January 9, 2019 at 10:34 pm | UPDATED: January 10, 2019 at 5:29 am
Categories:Business, Crime & Public Safety, Massachusetts, Nation, News
BOSTON, MA - JANUARY 9: Former chief executive of Insys Therapeutics Inc Michael Babich leaves the federal courthouse after pleading guilty to conspiracy to commit mail fraud in Boston, Massachusetts on January 9, 2019. (Staff Photo By Christopher Evans/Boston Herald)
A former pharmaceutical chief executive pleaded guilty to playing a part in a sophisticated scheme to give kickbacks to doctors who prescribed his company’s fentanyl-based opioid drugs — a move one top lawyer said is one step toward the goal of cutting down the corrupt greed that’s “alive and well in the pharma business.”
Michael Babich, the former CEO at Insys Therapeutics, pleaded guilty in federal court in Boston on Wednesday for his role in a nationwide scheme to bribe physicians to prescribe the company’s oral-spray painkillers meant for cancer patients facing extreme pain.
“It is very important that companies like Insys be held responsible for corrupting the medical community, as well as endangering and sometimes killing innocent patients,” said attorney Mike Moore, who’s leading some efforts to sue pharmaceutical companies two decades after securing a massive settlement against tobacco companies.
Moore, the former Mississippi attorney general, added, “Greed is alive and well in the pharma business and must be weeded out.”
Cases remain open against several of Babich’s alleged co-conspirators. The company paid half a million dollars two years ago after Massachusetts Attorney General Maura Healey’s office sued it on similar claims.
Sitting before a federal judge, Babich, 42, admitted he used Insys as a vehicle to bribe doctors into prescribing Subsys to patients who did not have cancer — a scheme that ended up lining his own pocket with $3.5 million more in profit, an amount he has agreed to give up. Those physicians would write Subsys prescriptions for no legitimate medical purpose, according to prosecutors.
Babich and the other officials disguised bribes and kickbacks in the form of speaking fees, the feds said, adding that Insys executives would punish those who didn’t write enough prescriptions.
Alec Burlakoff, a former sales vice president for Insys, pleaded guilty to racketeering conspiracy in November and agreed to cooperate with investigators. Babich, who faces up to 25 years behind bars, also will cooperate.
U.S. Attorney Andrew Lelling attended the court hearing Wednesday. His office declined to comment, citing the pending related cases.
Boston Mayor Martin J. Walsh said, “Boston has reached a breaking point in the fight against the opioid epidemic. We have a public health crisis on our hands that has steadily gotten worse in recent years and even though we have been increasing access to critical treatments and supports, we can’t fight this alone. It’s time to hold accountable the companies that created and fostered this crisis and pursue remedies to stop its harmful marketing tactics.”
2
Univec Conglomerate Inc (UNVC) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Here's a game-changer for the community. Valley Community Healthcare (VCH) is stepping up, proving that healthcare doesn't just stick to check-ups and prescriptions. It's about the whole shebang—community empowerment included. This October, VCH is hosting two incredible voter events, collaborating with the Los Angeles County Registrar-Recorder's Mobile Voting Program....
Continue Reading
Investors are no strangers to the rough and tumble of stock markets, but things get downright messy when trust is shattered. That's the sorry saga unfolding with AEVEX, where shareholders are feeling the heat after a sharp nosedive in stock value. The clock is ticking to join the class action, and any AEVEX investor worth their salt should pay attention. Unraveling...
Continue Reading
They've done it again, folks. LG Electronics is out there kicking up a storm with their all-new OLED evo W6 True Wireless Wallpaper TV, and they're bringing the action straight to the UAE's doorsteps. Imagine taking a stroll and stumbling upon this technological marvel at some fancy spot like The Lotus Lounge at Anantara The Palm Dubai Resort. This ain't just a TV, it's a...
Continue Reading
Breaking Ground in Patient Monitoring Let's dive into the gritty details behind Masimo's latest FDA-nod: the smartSET™ system. This gizmo ain't your ordinary pulse oximeter; it's a next-gen hand-holder for the medical world, poised to ride the AI wave straight into the clinic. They've cracked open a new way for clinicians to peek behind the curtain of patient vitals,...
Continue Reading
A Historical Meltdown into Global Recognition Welcome to the ride where ancient stones talk and cultural borders vanish. We're diving into the beating heart of Weifang, a place you're probably hearing about now because the town's hosting a packed international media tour. And, for a change, this isn't just another tourist trap; it's a cultural adrenaline shot to the arm,...
Continue Reading
Missteps at Innventure: A Costly Lesson in Investor Trust The stock market is no stranger to drama, but Innventure's saga feels like a page ripped right out of a thriller novel. You’ve got accusations, alleged fabrications, and a swift drop in stock prices that’s left some investors shaking their heads. The company, nestled under the ticker NASDAQ:INV, finds itself...
Continue Reading
Potential Shockwaves for Hyliion Investors Investors are having a showdown with Hyliion (NYSE:HYLN) these days. With the looming October 27, 2026, deadline to jump into a securities class action, it seems Hyliion's latest escapade smells worse than a fish market on a hot day. We’ve got allegations here stronger than your uncle’s morning coffee. Understanding the Legal...
Continue Reading
Top 5 Most Recently Viewed Articles
Semtech Corporation's Upcoming Q3 Earnings Announcement Semtech Corporation (NASDAQ: SMTX) is gearing up to share its earnings for the third quarter shortly after the market closes. Investors are keenly awaiting the results, as analysts have reported exciting projections. Expected Earnings Growth This quarter, analysts predict Semtech will report earnings of approximately...
Continue Reading
Updates from BioXcel Therapeutics on BXCL501 Trials BioXcel Therapeutics, Inc. (Nasdaq: BTAI) is making impressive progress in its clinical programs focused on treatments for agitation, particularly with their investigational product BXCL501. This biopharmaceutical firm uses innovative artificial intelligence in neuroscience and has recently shared updates that underscore...
Continue Reading
Collaboration Among California Health Plans for Primary Care In an exciting development in healthcare innovation, prominent California health plans have joined forces to implement a transformative payment model focused on enhancing primary care services. This unprecedented collaboration includes notable players like Aetna, Blue Shield of California, and Health Net, all...
Continue Reading
Introducing Petomg: Sustainable Cat Furniture for Modern Homes OMG International Trading Co., Limited has launched an innovative line of cat furniture branded as Petomg, inspired by the experience of rescuing a stray cat named Clover. This response to a domestic safety concern leads to a reinvention of pet furnishings, steering away from traditional particleboard options,...
Continue Reading
Partnership Highlights Nationwide 2-Day Delivery Shipium is excited to announce its partnership with ClearJet, a forward-thinking logistics powerhouse. This collaboration aims to revolutionize logistics solutions across the shipping landscape, allowing businesses to streamline their operations effortlessly. With Shipium's innovative shipping optimization platform and...
Continue Reading